Triglycerides and Triglyceride-Rich Particles in Health and Disease
健康和疾病中的甘油三酯和富含甘油三酯的颗粒
基本信息
- 批准号:7804073
- 负责人:
- 金额:$ 1.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-01-05 至 2011-01-04
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAdipose tissueAffectAnabolismAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAtherosclerosisBiologyCellsChylomicronsClinicalClinical SciencesClinical TrialsCoronary ArteriosclerosisDataDevelopmentDiseaseGeneticHealthHypertriglyceridemiaIndustryInsulinIntestinesLipidsLipolysisLipoproteinsLiverMedicineMetabolismMolecular BiologyMontanaNonesterified Fatty AcidsPathogenesisPharmacological TreatmentPlayPopulationRegulationResearchRoleScienceScientistSkiingTissuesTriglyceridesUpdateVery low density lipoproteinbasecardiovascular disorder riskclinically relevantcytokineenergy balanceinsightmeetingsparticlepublic health relevancesymposium
项目摘要
DESCRIPTION (provided by applicant):
This proposal is to request support for a Keystone Symposia meeting entitled Triglycerides and Triglyceride- Rich Particles in Health and Disease, organized by Robert H. Eckel, Ira J. Goldberg and Ruth McPherson, which will be held in Big Sky, Montana from January 9 - 14, 2010. Triglycerides are important storage molecules that play important roles in lipid and lipoprotein metabolism, insulin action, energy balance, and atherosclerosis. The purpose of this meeting will be to critically examine the broad spectrum of triglyceride biology from the molecular biology of triglyceride biosynthesis in the liver and intestine to lipoprotein assembly and secretion to lipid fuel partitioning to adipose tissue, muscle and the liver. A discussion of the regulation of free fatty acid flux from adipose tissue to the liver by insulin and pro- and anti-inflammatory cytokines will precede a detailed coverage of chylomicron and VLDL transport, intravascular lipolysis and tissue-specific lipid partitioning. A transition to the science and medicine of triglycerides will then occur with expected updates on the understanding of the genetic basis of disorders of triglyceride-rich lipoprotein metabolism and the pathogenesis of atherosclerosis that relate specifically to circulating triglyceride-rich particles. The clinical relevance of hypertriglyceridemia, new insights into the mechanisms of pharmacological treatment of hypertriglyceridemia, and clinical trial evidence pro and con that triglyceride lowering reduces cardiovascular disease risk will follow. The meeting should attract basic, clinical, and population scientists from academia and industry, and will deal with the many issues that remain unclear or controversial surrounding triglycerides and triglyceride rich particles in health and disease. PUBLIC HEALTH RELEVANCE: Research suggests that triglycerides are a cause of greater coronary artery disease; however, significant questions remain as to whether or not reducing triglyceride levels is protective. Moreover, the data relating the most severe forms of hypertriglyceridemia to development of atherosclerosis are limited. This Keystone Symposia meeting on Triglycerides and Triglyceride-Rich Particles in Health and Disease will assemble leading scientists to discuss 1) the clinical science on causes and treatment of hypertriglyceridemia, and 2) how triglycerides are regulated and affect biology in animals and cells.
描述(由申请人提供):
该建议是要求支持Keystone研讨会会议,题为“甘油三酸酯和甘油三酸酯 - 健康与疾病中富含甘油三酸酯的颗粒”,由罗伯特·H·埃克尔(Robert H.动作,能量平衡和动脉粥样硬化。这次会议的目的是批判性地检查肝脏和肠中甘油三酸酯生物合成的分子生物学的广泛甘油三酸酯生物学,从而向脂蛋白组装到脂质蛋白组装以及分泌脂质燃料分配到脂肪燃料,从而脂肪糖组织,肌肉和肌肉,肌肉和肝脏。讨论通过胰岛素以及促炎和抗炎细胞因子从脂肪组织到肝脏的游离脂肪酸通量的讨论将先于乳糜微粒和VLDL转运的详细覆盖,血管内脂肪解析以及组织特异性的脂质分析。然后,将对甘油三酸酯科学和医学的过渡进行预期的更新,以了解对富含甘油三酸酯的脂蛋白代谢的遗传基础的理解以及动脉粥样硬化的发病机理,这些发病机理与富含甘油三酸酯的颗粒特别相关。高甘油三酯血症的临床相关性,对高甘油三酯血症药理治疗机制的新见解以及临床试验证据Pro和CON降低了甘油三酸酯的降低心血管疾病风险。这次会议应吸引来自学术界和工业的基本,临床和人群科学家,并将处理许多在健康和疾病中尚不清楚或有争议的问题。公共卫生相关性:研究表明,甘油三酸酯是冠状动脉疾病更大的原因。但是,关于降低甘油三酸酯水平是否具有保护性仍然存在的重大问题。此外,将最严重的高甘油三酯血症与动脉粥样硬化发展有关的数据受到限制。这次有关甘油三酸酯和甘油三酸酯富含甘油三酸酯的颗粒的Keystone研讨会将组装领导科学家讨论1)关于高甘油三酯血症的原因和治疗的临床科学,以及2)如何调节甘油三酸酯,并影响动物和细胞的生物学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW D ROBERTSON其他文献
ANDREW D ROBERTSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW D ROBERTSON', 18)}}的其他基金
Mechanisms of Cardiac Growth, Death and Regeneration
心脏生长、死亡和再生的机制
- 批准号:
8056942 - 财政年份:2011
- 资助金额:
$ 1.8万 - 项目类别:
Environmental Epigenomics and Disease Susceptibility
环境表观基因组学和疾病易感性
- 批准号:
8130161 - 财政年份:2011
- 资助金额:
$ 1.8万 - 项目类别:
Mycobacteria: Physiology, Metabolism and Pathogenesis - Back to the Basics
分枝杆菌:生理学、代谢和发病机制 - 回到基础
- 批准号:
8055811 - 财政年份:2011
- 资助金额:
$ 1.8万 - 项目类别:
Immunity in the Respiratory Tract: Challenges of the Lung Environment
呼吸道免疫:肺部环境的挑战
- 批准号:
8057229 - 财政年份:2011
- 资助金额:
$ 1.8万 - 项目类别:
Pathogenesis of Influenza: Virus-Host Interactions
流感的发病机制:病毒与宿主的相互作用
- 批准号:
8128073 - 财政年份:2011
- 资助金额:
$ 1.8万 - 项目类别:
Drugs from Bugs: The Anti-Inflammatory Drugs of Tomorrow
昆虫药物:明天的抗炎药物
- 批准号:
8124051 - 财政年份:2011
- 资助金额:
$ 1.8万 - 项目类别:
Tuberculosis: Immunology, Cell Biology and Novel Vaccination Strategies
结核病:免疫学、细胞生物学和新型疫苗接种策略
- 批准号:
8055809 - 财政年份:2011
- 资助金额:
$ 1.8万 - 项目类别:
NK and NKT Cell Biology: Specificity and Redundancy of Innate Responses
NK 和 NKT 细胞生物学:先天反应的特异性和冗余
- 批准号:
8006107 - 财政年份:2011
- 资助金额:
$ 1.8万 - 项目类别:
相似国自然基金
新型BPA替代品BPSIP生命早期暴露对子代脂肪组织发育的影响及表观遗传机制
- 批准号:22306173
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
肥胖脂肪组织小囊泡转运鞘磷脂调控鞘磷脂水解代谢促进破骨分化影响骨质疏松的机制研究
- 批准号:32300985
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ANGPTLs基因及其蛋白表达水平调控内脏脂肪组织影响健康衰老表型的前瞻性队列研究
- 批准号:82373661
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
脂肪组织中SIRT3通过抑制外泌体miR-30a-3p调控肝脏自噬影响非酒精性脂肪肝病的机制研究
- 批准号:32360174
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
FTL+ALB+脂肪干细胞与CD36+EBF2-内皮细胞通过交互作用影响脂肪组织衰老的机制研究
- 批准号:82370884
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Ubiquitin D as a potential therapeutic target for NASH, HCC and chronic kidney diseases
泛素 D 作为 NASH、HCC 和慢性肾脏疾病的潜在治疗靶点
- 批准号:
10666292 - 财政年份:2023
- 资助金额:
$ 1.8万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10514629 - 财政年份:2020
- 资助金额:
$ 1.8万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10337048 - 财政年份:2020
- 资助金额:
$ 1.8万 - 项目类别:
2nd Cancer Cachexia Conference: Evolving Mechanisms and Therapies
第二届癌症恶病质会议:不断发展的机制和疗法
- 批准号:
8785905 - 财政年份:2014
- 资助金额:
$ 1.8万 - 项目类别: